-
1
-
-
78449281377
-
Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials
-
C. Baigent, L. Blackwell, J. Emberson, L.E. Holland, C. Reith, N. Bhala, R. Peto, E.H. Barnes, A. Keech, J. Simes, and R. Collins Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials Lancet 376 2010 1670 1681
-
(2010)
Lancet
, vol.376
, pp. 1670-1681
-
-
Baigent, C.1
Blackwell, L.2
Emberson, J.3
Holland, L.E.4
Reith, C.5
Bhala, N.6
Peto, R.7
Barnes, E.H.8
Keech, A.9
Simes, J.10
Collins, R.11
-
2
-
-
79960539641
-
ESC/EAS guidelines for the management of dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
-
Z. Reiner, A.L. Catapano, G. De Backer, I. Graham, M.R. Taskinen, O. Wiklund, S. Agewall, E. Alegria, M.J. Chapman, P. Durrington, S. Erdine, J. Halcox, R. Hobbs, J. Kjekshus, P.P. Filardi, G. Riccardi, R.F. Storey, and D. Wood ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J 32 2011 1769 1818
-
(2011)
Eur Heart J
, vol.32
, pp. 1769-1818
-
-
Reiner, Z.1
Catapano, A.L.2
De Backer, G.3
Graham, I.4
Taskinen, M.R.5
Wiklund, O.6
Agewall, S.7
Alegria, E.8
Chapman, M.J.9
Durrington, P.10
Erdine, S.11
Halcox, J.12
Hobbs, R.13
Kjekshus, J.14
Filardi, P.P.15
Riccardi, G.16
Storey, R.F.17
Wood, D.18
-
3
-
-
84902576469
-
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
-
N.J. Stone, J.G. Robinson, A.H. Lichtenstein, C.N. Bairey Merz, C.B. Blum, R.H. Eckel, A.C. Goldberg, D. Gordon, D. Levy, D.M. Lloyd-Jones, P. McBride, J.S. Schwartz, S.T. Shero, S.C. Smith Jr., K. Watson, and P.W. Wilson 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 2014 2889 2934
-
(2014)
J Am Coll Cardiol
, vol.63
, pp. 2889-2934
-
-
Stone, N.J.1
Robinson, J.G.2
Lichtenstein, A.H.3
Bairey Merz, C.N.4
Blum, C.B.5
Eckel, R.H.6
Goldberg, A.C.7
Gordon, D.8
Levy, D.9
Lloyd-Jones, D.M.10
McBride, P.11
Schwartz, J.S.12
Shero, S.T.13
Smith, S.C.14
Watson, K.15
Wilson, P.W.16
-
4
-
-
80051755356
-
Imaging biomarkers in atherosclerosis trials
-
J.C. Tardif, F. Lesage, F. Harel, P. Romeo, and J. Pressacco Imaging biomarkers in atherosclerosis trials Circ Cardiovasc Imaging 4 2011 319 333
-
(2011)
Circ Cardiovasc Imaging
, vol.4
, pp. 319-333
-
-
Tardif, J.C.1
Lesage, F.2
Harel, F.3
Romeo, P.4
Pressacco, J.5
-
5
-
-
77952205006
-
Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome
-
S.J. Nicholls, A. Hsu, K. Wolski, B. Hu, O. Bayturan, A. Lavoie, K. Uno, E.M. Tuzcu, and S.E. Nissen Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome J Am Coll Cardiol 55 2010 2399 2407
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 2399-2407
-
-
Nicholls, S.J.1
Hsu, A.2
Wolski, K.3
Hu, B.4
Bayturan, O.5
Lavoie, A.6
Uno, K.7
Tuzcu, E.M.8
Nissen, S.E.9
-
6
-
-
84872791483
-
Left main coronary atherosclerosis progression, constrictive remodeling, and clinical events
-
R. Puri, K. Wolski, K. Uno, Y. Kataoka, K.L. King, T.D. Crowe, S.R. Kapadia, E.M. Tuzcu, S.E. Nissen, and S.J. Nicholls Left main coronary atherosclerosis progression, constrictive remodeling, and clinical events JACC Cardiovasc Interv 6 2013 29 35
-
(2013)
JACC Cardiovasc Interv
, vol.6
, pp. 29-35
-
-
Puri, R.1
Wolski, K.2
Uno, K.3
Kataoka, Y.4
King, K.L.5
Crowe, T.D.6
Kapadia, S.R.7
Tuzcu, E.M.8
Nissen, S.E.9
Nicholls, S.J.10
-
7
-
-
10744225301
-
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial
-
S.E. Nissen, E.M. Tuzcu, P. Schoenhagen, B.G. Brown, P. Ganz, R.A. Vogel, T. Crowe, G. Howard, C.J. Cooper, B. Brodie, C.L. Grines, and A.N. DeMaria Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial JAMA 291 2004 1071 1080
-
(2004)
JAMA
, vol.291
, pp. 1071-1080
-
-
Nissen, S.E.1
Tuzcu, E.M.2
Schoenhagen, P.3
Brown, B.G.4
Ganz, P.5
Vogel, R.A.6
Crowe, T.7
Howard, G.8
Cooper, C.J.9
Brodie, B.10
Grines, C.L.11
Demaria, A.N.12
-
8
-
-
33645524176
-
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial
-
S.E. Nissen, S.J. Nicholls, I. Sipahi, P. Libby, J.S. Raichlen, C.M. Ballantyne, J. Davignon, R. Erbel, J.C. Fruchart, J.C. Tardif, P. Schoenhagen, T. Crowe, V. Cain, K. Wolski, M. Goormastic, and E.M. Tuzcu Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial JAMA 295 2006 1556 1565
-
(2006)
JAMA
, vol.295
, pp. 1556-1565
-
-
Nissen, S.E.1
Nicholls, S.J.2
Sipahi, I.3
Libby, P.4
Raichlen, J.S.5
Ballantyne, C.M.6
Davignon, J.7
Erbel, R.8
Fruchart, J.C.9
Tardif, J.C.10
Schoenhagen, P.11
Crowe, T.12
Cain, V.13
Wolski, K.14
Goormastic, M.15
Tuzcu, E.M.16
-
9
-
-
82555168428
-
Effect of two intensive statin regimens on progression of coronary disease
-
S.J. Nicholls, C.M. Ballantyne, P.J. Barter, M.J. Chapman, R.M. Erbel, P. Libby, J.S. Raichlen, K. Uno, M. Borgman, K. Wolski, and S.E. Nissen Effect of two intensive statin regimens on progression of coronary disease N Engl J Med 365 2011 2078 2087
-
(2011)
N Engl J Med
, vol.365
, pp. 2078-2087
-
-
Nicholls, S.J.1
Ballantyne, C.M.2
Barter, P.J.3
Chapman, M.J.4
Erbel, R.M.5
Libby, P.6
Raichlen, J.S.7
Uno, K.8
Borgman, M.9
Wolski, K.10
Nissen, S.E.11
-
10
-
-
84884182403
-
Effect of aliskiren on progression of coronary disease in patients with prehypertension: The AQUARIUS randomized clinical trial
-
S.J. Nicholls, G.L. Bakris, J.J. Kastelein, V. Menon, B. Williams, J. Armbrecht, P. Brunel, M. Nicolaides, A. Hsu, B. Hu, H. Fang, R. Puri, K. Uno, Y. Kataoka, D. Bash, and S.E. Nissen Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trial JAMA 310 2013 1135 1144
-
(2013)
JAMA
, vol.310
, pp. 1135-1144
-
-
Nicholls, S.J.1
Bakris, G.L.2
Kastelein, J.J.3
Menon, V.4
Williams, B.5
Armbrecht, J.6
Brunel, P.7
Nicolaides, M.8
Hsu, A.9
Hu, B.10
Fang, H.11
Puri, R.12
Uno, K.13
Kataoka, Y.14
Bash, D.15
Nissen, S.E.16
-
11
-
-
33645097996
-
Effect of ACAT inhibition on the progression of coronary atherosclerosis
-
Investigators AIATE
-
S.E. Nissen, E.M. Tuzcu, H.B. Brewer, I. Sipahi, S.J. Nicholls, P. Ganz, P. Schoenhagen, D.D. Waters, C.J. Pepine, T.D. Crowe, M.H. Davidson, J.E. Deanfield, L.M. Wisniewski, J.J. Hanyok, L.M. Kassalow Investigators AIATE Effect of ACAT inhibition on the progression of coronary atherosclerosis N Engl J Med 354 2006 1253 1263
-
(2006)
N Engl J Med
, vol.354
, pp. 1253-1263
-
-
Nissen, S.E.1
Tuzcu, E.M.2
Brewer, H.B.3
Sipahi, I.4
Nicholls, S.J.5
Ganz, P.6
Schoenhagen, P.7
Waters, D.D.8
Pepine, C.J.9
Crowe, T.D.10
Davidson, M.H.11
Deanfield, J.E.12
Wisniewski, L.M.13
Hanyok, J.J.14
Kassalow, L.M.15
-
12
-
-
34047106220
-
Effect of torcetrapib on the progression of coronary atherosclerosis
-
S.E. Nissen, J.C. Tardif, S.J. Nicholls, J.H. Revkin, C.L. Shear, W.T. Duggan, W. Ruzyllo, W.B. Bachinsky, G.P. Lasala, and E.M. Tuzcu Effect of torcetrapib on the progression of coronary atherosclerosis N Engl J Med 356 2007 1304 1316
-
(2007)
N Engl J Med
, vol.356
, pp. 1304-1316
-
-
Nissen, S.E.1
Tardif, J.C.2
Nicholls, S.J.3
Revkin, J.H.4
Shear, C.L.5
Duggan, W.T.6
Ruzyllo, W.7
Bachinsky, W.B.8
Lasala, G.P.9
Tuzcu, E.M.10
-
13
-
-
41649090426
-
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: The STRADIVARIUS randomized controlled trial
-
S.E. Nissen, S.J. Nicholls, K. Wolski, J. Rodes-Cabau, C.P. Cannon, J.E. Deanfield, J.P. Despres, J.J. Kastelein, S.R. Steinhubl, S. Kapadia, M. Yasin, W. Ruzyllo, C. Gaudin, B. Job, B. Hu, D.L. Bhatt, A.M. Lincoff, and E.M. Tuzcu Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial JAMA 299 2008 1547 1560
-
(2008)
JAMA
, vol.299
, pp. 1547-1560
-
-
Nissen, S.E.1
Nicholls, S.J.2
Wolski, K.3
Rodes-Cabau, J.4
Cannon, C.P.5
Deanfield, J.E.6
Despres, J.P.7
Kastelein, J.J.8
Steinhubl, S.R.9
Kapadia, S.10
Yasin, M.11
Ruzyllo, W.12
Gaudin, C.13
Job, B.14
Hu, B.15
Bhatt, D.L.16
Lincoff, A.M.17
Tuzcu, E.M.18
-
14
-
-
41649084422
-
Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: The PERISCOPE randomized controlled trial
-
S.E. Nissen, S.J. Nicholls, K. Wolski, R. Nesto, S. Kupfer, A. Perez, H. Jure, R. De Larochelliere, C.S. Staniloae, K. Mavromatis, J. Saw, B. Hu, A.M. Lincoff, and E.M. Tuzcu Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial JAMA 299 2008 1561 1573
-
(2008)
JAMA
, vol.299
, pp. 1561-1573
-
-
Nissen, S.E.1
Nicholls, S.J.2
Wolski, K.3
Nesto, R.4
Kupfer, S.5
Perez, A.6
Jure, H.7
De Larochelliere, R.8
Staniloae, C.S.9
Mavromatis, K.10
Saw, J.11
Hu, B.12
Lincoff, A.M.13
Tuzcu, E.M.14
-
15
-
-
36348975228
-
Effects of torcetrapib in patients at high risk for coronary events
-
P.J. Barter, M. Caulfield, M. Eriksson, S.M. Grundy, J.J. Kastelein, M. Komajda, J. Lopez-Sendon, L. Mosca, J.C. Tardif, D.D. Waters, C.L. Shear, J.H. Revkin, K.A. Buhr, M.R. Fisher, A.R. Tall, and B. Brewer Effects of torcetrapib in patients at high risk for coronary events N Engl J Med 357 2007 2109 2122
-
(2007)
N Engl J Med
, vol.357
, pp. 2109-2122
-
-
Barter, P.J.1
Caulfield, M.2
Eriksson, M.3
Grundy, S.M.4
Kastelein, J.J.5
Komajda, M.6
Lopez-Sendon, J.7
Mosca, L.8
Tardif, J.C.9
Waters, D.D.10
Shear, C.L.11
Revkin, J.H.12
Buhr, K.A.13
Fisher, M.R.14
Tall, A.R.15
Brewer, B.16
-
16
-
-
0242577955
-
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: A randomized controlled trial
-
S.E. Nissen, T. Tsunoda, E.M. Tuzcu, P. Schoenhagen, C.J. Cooper, M. Yasin, G.M. Eaton, M.A. Lauer, W.S. Sheldon, C.L. Grines, S. Halpern, T. Crowe, J.C. Blankenship, and R. Kerensky Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial JAMA 290 2003 2292 2300
-
(2003)
JAMA
, vol.290
, pp. 2292-2300
-
-
Nissen, S.E.1
Tsunoda, T.2
Tuzcu, E.M.3
Schoenhagen, P.4
Cooper, C.J.5
Yasin, M.6
Eaton, G.M.7
Lauer, M.A.8
Sheldon, W.S.9
Grines, C.L.10
Halpern, S.11
Crowe, T.12
Blankenship, J.C.13
Kerensky, R.14
-
17
-
-
7744231805
-
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: The CAMELOT study: A randomized controlled trial
-
S.E. Nissen, E.M. Tuzcu, P. Libby, P.D. Thompson, M. Ghali, D. Garza, L. Berman, H. Shi, E. Buebendorf, and E.J. Topol Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial JAMA 292 2004 2217 2225
-
(2004)
JAMA
, vol.292
, pp. 2217-2225
-
-
Nissen, S.E.1
Tuzcu, E.M.2
Libby, P.3
Thompson, P.D.4
Ghali, M.5
Garza, D.6
Berman, L.7
Shi, H.8
Buebendorf, E.9
Topol, E.J.10
-
18
-
-
0347926134
-
Variability of area measurements obtained with different intravascular ultrasound catheter systems: Impact on clinical trials and a method for accurate calibration
-
P. Schoenhagen, S.K. Sapp, E.M. Tuzcu, W.A. Magyar, J. Popovich, M. Boumitri, D.G. Vince, T. Crowe, and S.E. Nissen Variability of area measurements obtained with different intravascular ultrasound catheter systems: impact on clinical trials and a method for accurate calibration J Am Soc Echocardiogr 16 2003 277 284
-
(2003)
J Am Soc Echocardiogr
, vol.16
, pp. 277-284
-
-
Schoenhagen, P.1
Sapp, S.K.2
Tuzcu, E.M.3
Magyar, W.A.4
Popovich, J.5
Boumitri, M.6
Vince, D.G.7
Crowe, T.8
Nissen, S.E.9
-
19
-
-
0037031061
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
-
(2002)
Lancet
, vol.360
, pp. 7-22
-
-
-
20
-
-
84900406485
-
Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease?: Clinical risk scores are not sufficient to define primary prevention treatment strategies among asymptomatic patients
-
M.J. Blaha, M.G. Silverman, and M.J. Budoff Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease?: Clinical risk scores are not sufficient to define primary prevention treatment strategies among asymptomatic patients Circ Cardiovasc Imaging 7 2014 398 408
-
(2014)
Circ Cardiovasc Imaging
, vol.7
, pp. 398-408
-
-
Blaha, M.J.1
Silverman, M.G.2
Budoff, M.J.3
-
21
-
-
72449189674
-
Re-evaluating the Rose approach: Comparative benefits of the population and high-risk preventive strategies
-
Investigators S
-
M.T. Cooney, A. Dudina, P. Whincup, S. Capewell, A. Menotti, P. Jousilahti, I. Njolstad, R. Oganov, T. Thomsen, A. Tverdal, H. Wedel, L. Wilhelmsen, I. Graham Investigators S Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies Eur J Cardiovasc Prev Rehabil 16 2009 541 549
-
(2009)
Eur J Cardiovasc Prev Rehabil
, vol.16
, pp. 541-549
-
-
Cooney, M.T.1
Dudina, A.2
Whincup, P.3
Capewell, S.4
Menotti, A.5
Jousilahti, P.6
Njolstad, I.7
Oganov, R.8
Thomsen, T.9
Tverdal, A.10
Wedel, H.11
Wilhelmsen, L.12
Graham, I.13
-
22
-
-
84890059009
-
Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy
-
R. Puri, S.E. Nissen, M. Shao, C.M. Ballantyne, P.J. Barter, M.J. Chapman, R. Erbel, P. Libby, J.S. Raichlen, K. Uno, Y. Kataoka, and S.J. Nicholls Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy Eur Heart J 34 2013 3182 3190
-
(2013)
Eur Heart J
, vol.34
, pp. 3182-3190
-
-
Puri, R.1
Nissen, S.E.2
Shao, M.3
Ballantyne, C.M.4
Barter, P.J.5
Chapman, M.J.6
Erbel, R.7
Libby, P.8
Raichlen, J.S.9
Uno, K.10
Kataoka, Y.11
Nicholls, S.J.12
-
23
-
-
0037078969
-
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
-
P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
-
(2002)
N Engl J Med
, vol.347
, pp. 1557-1565
-
-
Ridker, P.M.1
Rifai, N.2
Rose, L.3
Buring, J.E.4
Cook, N.R.5
-
24
-
-
84884322622
-
High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy
-
S. Mora, R.J. Glynn, and P.M. Ridker High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy Circulation 128 2013 1189 1197
-
(2013)
Circulation
, vol.128
, pp. 1189-1197
-
-
Mora, S.1
Glynn, R.J.2
Ridker, P.M.3
-
25
-
-
33645741889
-
Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial
-
J.D. Otvos, D. Collins, D.S. Freedman, I. Shalaurova, E.J. Schaefer, J.R. McNamara, H.E. Bloomfield, and S.J. Robins Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial Circulation 113 2006 1556 1563
-
(2006)
Circulation
, vol.113
, pp. 1556-1563
-
-
Otvos, J.D.1
Collins, D.2
Freedman, D.S.3
Shalaurova, I.4
Schaefer, E.J.5
McNamara, J.R.6
Bloomfield, H.E.7
Robins, S.J.8
-
26
-
-
84893281581
-
Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events
-
S. Mora, J.E. Buring, and P.M. Ridker Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events Circulation 129 2014 553 561
-
(2014)
Circulation
, vol.129
, pp. 553-561
-
-
Mora, S.1
Buring, J.E.2
Ridker, P.M.3
-
27
-
-
58249086417
-
Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk
-
J.G. Robinson, S. Wang, B.J. Smith, and T.A. Jacobson Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk J Am Coll Cardiol 53 2009 316 322
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 316-322
-
-
Robinson, J.G.1
Wang, S.2
Smith, B.J.3
Jacobson, T.A.4
-
28
-
-
84859184996
-
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: A meta-analysis
-
S.M. Boekholdt, B.J. Arsenault, S. Mora, T.R. Pedersen, J.C. LaRosa, P.J. Nestel, R.J. Simes, P. Durrington, G.A. Hitman, K.M. Welch, D.A. DeMicco, A.H. Zwinderman, M.B. Clearfield, J.R. Downs, A.M. Tonkin, H.M. Colhoun, A.M. Gotto Jr., P.M. Ridker, and J.J. Kastelein Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis JAMA 307 2012 1302 1309
-
(2012)
JAMA
, vol.307
, pp. 1302-1309
-
-
Boekholdt, S.M.1
Arsenault, B.J.2
Mora, S.3
Pedersen, T.R.4
Larosa, J.C.5
Nestel, P.J.6
Simes, R.J.7
Durrington, P.8
Hitman, G.A.9
Welch, K.M.10
Demicco, D.A.11
Zwinderman, A.H.12
Clearfield, M.B.13
Downs, J.R.14
Tonkin, A.M.15
Colhoun, H.M.16
Gotto, A.M.17
Ridker, P.M.18
Kastelein, J.J.19
-
29
-
-
56749106312
-
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
-
P.M. Ridker, E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto Jr., J.J. Kastelein, W. Koenig, P. Libby, A.J. Lorenzatti, J.G. MacFadyen, B.G. Nordestgaard, J. Shepherd, J.T. Willerson, and R.J. Glynn Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
-
(2008)
N Engl J Med
, vol.359
, pp. 2195-2207
-
-
Ridker, P.M.1
Danielson, E.2
Fonseca, F.A.3
Genest, J.4
Gotto, A.M.5
Kastelein, J.J.6
Koenig, W.7
Libby, P.8
Lorenzatti, A.J.9
Macfadyen, J.G.10
Nordestgaard, B.G.11
Shepherd, J.12
Willerson, J.T.13
Glynn, R.J.14
-
30
-
-
84896925167
-
Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: Insights from SATURN
-
R. Puri, P. Libby, S.E. Nissen, K. Wolski, C.M. Ballantyne, P.J. Barter, M.J. Chapman, R. Erbel, J.S. Raichlen, K. Uno, Y. Kataoka, E.M. Tuzcu, and S.J. Nicholls Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN Eur Heart J Cardiovasc Imaging 15 2014 380 388
-
(2014)
Eur Heart J Cardiovasc Imaging
, vol.15
, pp. 380-388
-
-
Puri, R.1
Libby, P.2
Nissen, S.E.3
Wolski, K.4
Ballantyne, C.M.5
Barter, P.J.6
Chapman, M.J.7
Erbel, R.8
Raichlen, J.S.9
Uno, K.10
Kataoka, Y.11
Tuzcu, E.M.12
Nicholls, S.J.13
|